Drug Interactions between dimercaprol and L'il Critters Immune C Plus Zinc Plus Vitamin D Gummy
This report displays the potential drug interactions for the following 2 drugs:
- dimercaprol
- L'il Critters Immune C Plus Zinc Plus Vitamin D Gummy (multivitamin with minerals)
Interactions between your drugs
dimercaprol multivitamin with minerals
Applies to: dimercaprol and L'il Critters Immune C Plus Zinc Plus Vitamin D Gummy (multivitamin with minerals)
ADJUST DOSING INTERVAL: Dimercaprol can form a nephrotoxic chelate with certain metals such as cadmium, iron, and selenium.
MANAGEMENT: Preparations containing iron or selenium salts should not be administered during chelation therapy with dimercaprol and for at least 24 hours after the last dose of dimercaprol.
References (3)
- Seffart G ed. (1991) "Drug Dosage in Renal Insufficiency." Dordrecht, South Holland, : Kluwer Academic Publishers
- Chenoweth MB (1968) "Clinical uses of metal-binding drugs." Clin Pharmacol Ther, 9, p. 365-87
- (2022) "Product Information. BAL In Oil (dimercaprol)." Apothecon Inc
Drug and food interactions
dimercaprol food
Applies to: dimercaprol
ADJUST DOSING INTERVAL: Dimercaprol can form a nephrotoxic chelate with certain metals such as cadmium, iron, and selenium.
MANAGEMENT: Preparations containing iron or selenium salts should not be administered during chelation therapy with dimercaprol and for at least 24 hours after the last dose of dimercaprol.
References (3)
- Seffart G ed. (1991) "Drug Dosage in Renal Insufficiency." Dordrecht, South Holland, : Kluwer Academic Publishers
- Chenoweth MB (1968) "Clinical uses of metal-binding drugs." Clin Pharmacol Ther, 9, p. 365-87
- (2022) "Product Information. BAL In Oil (dimercaprol)." Apothecon Inc
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.